Latest Research News: Landmark dataset to accelerate research on anterior segment eye disease

Orginal Article from INSIGHT Health Data Research Hub  Diseases affecting the anterior segment, the front part of the eye, are among the leading causes of visual impairment and blindness globally, yet few large-scale datasets have been available for these conditions. In response, clinical researchers at Moorfields Eye Hospital NHS Foundation Trust and University College London…

Keratoconus and Other Health Conditions: Any Cause for Concern?

By Dr Waheeda IllahiBased on Dr Illahi’s talk at the Keratoconus Group AGM For many people living with keratoconus, the focus is understandably on vision: diagnosis, contact lenses, cross-linking, hospital appointments, and trying to manage day-to-day life. But at this year’s AGM, Dr Waheeda Illahi encouraged us to think more broadly about the person behind…

Join our New Whatsapp Community

Living with keratoconus can sometimes feel isolating. Whether you’ve been recently diagnosed, are managing changes in your vision, or are supporting someone you care about, it helps to know you’re not alone. That’s why we’re pleased to introduce our brand new WhatsApp Community — a dedicated space created by The Keratoconus Group to help people…

Glaukos Announces FDA Approval of Epioxa™

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, IncisionFree, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for Patients Afflicted by This Sight-Threatening Rare Disease Epioxa Expected to Be Commercially Available in Q1 2026 Aliso Viejo, CA – October 20, 2025 – Glaukos Corporation (NYSE: GKOS), an…